InvestorsHub Logo
Followers 34
Posts 2400
Boards Moderated 0
Alias Born 06/15/2007

Re: biosectinvestor post# 249249

Monday, 10/28/2019 6:10:18 PM

Monday, October 28, 2019 6:10:18 PM

Post# of 727202
NWBO is writing SAPS based on the information they believe unblinding will yield.

Based on the presumed info the unblinding will yield / the SAP is designed to concur with most all the data that becomes available.

They can’t possible know everything that the unblind will yield but they are writing in expected contingencies that may or may not occur.

They only get one chance to unblind the data and the SAPS need to jive with the data

Looking out for most all the possible exceptions

PRE 5-ALA - post 5-ALA

CERTAIN antigen markers etc

I definitely think we are close and I am also getting impatient

But i also think the risk to reward to great to give up

Many reasons lead me to ride it out

The 69 physicians with there name on the trial who believe in this

Long tail

All the negative posters who claim they don’t own NWBO, claim not short
Just here !!! To make sure everyone else understands this can’t possibly succeed based on a trivial minutia

They often make valid points with minor detail twists to muddy the waters blah blah blah

I can’t name them because it will violate TOS but we all know who they are

I think the 4 yr Mark since last patient dosed will start the cascade of news before the end of this year


I will say if we don’t have unblinding before FEB 2020 I will be quite disappointed and may reconsider my investment

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News